Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Rollover participants are eligible for the study if they met the following inclusion criteria:
Key Exclusion criteria:
Rollover participants are excluded from the trial if any of the following met:
Primary purpose
Allocation
Interventional model
Masking
1,200 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal